Showing 20 of 107 recruiting trials for “acute-undifferentiated-leukemia”
Pacritinib, a Kinase Inhibitor of CSF1R, IRAK1, JAK2, and FLT3, in Adults and Pediatric Participants 12 Years of Age or Older With Myelodysplastic Syndromes or Myelodysplastic/Myeloproliferative Neoplasms
A Single-arm, Prospective Study of a Cladribine-Bridged LABU Conditioning Regimen in Allogeneic Hematopoietic Stem Cell Transplantation for Relapsed/Refractory MDS/AML in Elderly Patients
👨⚕️ Depei Wu, The First Affiliated Hospital of Soochow University📍 1 site📅 Started Apr 2026View details ↗
A Study to Compare Elritercept With Epoetin Alfa to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions
Olutasidenib DDI Study in Patients With IDH1 Mutation Positive Malignancies
Safety and Proof-of-Concept Study of RPT1G in Adults With Acute Myeloid Leukemia and High-Risk Myelodysplastic Syndromes
Phase Ib Study of CD33 FPBMC in Patients With MRD+ AML or MDS
Feasibility Trial of Extracorporeal Iron Purification in Patients With Myelodysplastic Syndrome or Myelofibrosis
Induction and Consolidation With Fludarabine, Cytarabine, Idarubicin, and Venetoclax for the Treatment of Acute Myeloid Leukemia
Phase I Trial for Patients w/ Advanced Hematologic Malignancies Undergoing Allogeneic HCT
Combination Chemotherapy (FLAG-Ida) Followed Immediately by Reduced-Intensity Total Body Radiation Therapy and Donor Hematopoietic Cell Transplant for the Treatment of Adults Age 60 and Older With Newly Diagnosed Adverse-Risk Acute Myeloid Leukemia or Other High-Grade Myeloid Cancer
👨⚕️ Filippo Milano, MD, PhD, Fred Hutch/University of Washington Cancer Consortium📍 1 site📅 Started Sep 2025View details ↗
Leflunomide in Combination With Decitabine for Treatment of Relapsed or Refractory Myelodysplastic Syndromes
A Phase 1 Study of AOH1996 in Patients With Relapsed/Refractory Acute Myeloid Leukemia
ONC-LEUK-2406: The Impact of Systematic Financial Navigation in Acute Myeloid Leukemia
👨⚕️ Thomas Knight, MD, Wake Forest University Health Sciences📍 2 sites📅 Started Jun 2025View details ↗
VAM in Secondary AML, AML With Extramedullary Involvement, and Myeloid Sarcoma
A Study of Momelotinib in Participants With Low-risk Myelodysplastic Syndrome
Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia
A Study of Azacitidine and Venetoclax Versus a Stem Cell Transplant in People 65 Years and Older With Acute Myeloid Leukemia
👨⚕️ Roni Tamari, MD, Memorial Sloan Kettering Cancer Center📍 7 sites📅 Started Jun 2025View details ↗
A Study of Oral Tetrahydrouridine-Decitabine in Relapsed or Refractory Myelodysplastic Syndromes (MDS)
👨⚕️ Mendel Goldfinger, MD, Montefiore/Einstein Cancer Center📍 1 site📅 Started Jun 2025View details ↗
Romiplostim N01 for Platelet Recovery After Haploidentical HSCT
XP-005 Personalized Vaccine Alone or in Combination With Toripalimab for the Prevention of Relapse After Remission in Acute Myeloid Leukemia
Page 1 of 6Next →
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →